Rhenman & Partners Asset Management’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-37,000
| Closed | -$944K | – | 84 |
|
|
2020
Q3 | $944K | Hold |
37,000
| – | – | 0.08% | 78 |
|
|
2020
Q2 | $2.7M | Sell |
37,000
-1,000
| -3% | -$72.9K | 0.29% | 77 |
|
|
2020
Q1 | $2M | Sell |
38,000
-2,000
| -5% | -$105K | 0.28% | 76 |
|
|
2019
Q4 | $3.27M | Hold |
40,000
| – | – | 0.36% | 75 |
|
|
2019
Q3 | $2.26M | Buy |
40,000
+14,035
| +54% | +$793K | 0.28% | 73 |
|
|
2019
Q2 | $3.1M | Hold |
25,965
| – | – | 0.34% | 66 |
|
|
2019
Q1 | $4.78M | Hold |
25,965
| – | – | 0.56% | 60 |
|
|
2018
Q4 | $4.64M | Buy |
+25,965
| New | +$4.64M | 0.53% | 59 |
|